Pharma Clinical Trial Services Market Forecast Up to 2030

The pharma clinical trials services market is expected to grow at a CAGR of 10% in the first half of the forecast period and be worth $150.15bn by 2030.
NEW YORK - June 14, 2021 - PRLog -- Visiongain has launched a new pharma report: Pharma Clinical Trial Services Market and Industry Forecast 2020-2030: Early Phase Services, Late Phase Services, Other Services, Pharma, Biotech, Other End-users, Cancer, Cardiovascular Diseases, CNS, Infectious Diseases, Metabolic Diseases, Other Disease.

This report encompasses the global market for pharmaceutical clinical trial services. It provides a comprehensive and critical analysis of the market, including the subsectors of early phase services and late phase services. The report also assesses the key therapeutic areas in which leading clinical research organizations (CROs) operate, namely, cancer, cardiovascular disease, CNS disease, infectious diseases and metabolic disease.

Download Exclusive Sample of Report @

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 220-page report you will receive 51 tables and 110 figures– all unavailable elsewhere.

The 220-page report provides clear detailed insight into the pharma clinical trial services market. Discover the key drivers and challenges affecting the market.

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.

About Visiongain
Visiongain is one of the fastest-growing and most innovative independent market research and consulting company in London, UK,

Sara Peerun
Commercial Director at Visiongain Limited

Like PRLog?
Click to Share